ASX Medical Cannabis Player Hits First Retail Sales in US$460BN...

Column 1

0

​ ASX Medical Cannabis Player Hits First Retail Sales in US$460BN Cosmetics Market​ As government legislation moves closer to making medical cannabis a flourishing commercial industry, companies across the various sectors where this will have an influence are making moves to capitalise.​ One ASX listed $40 million capped company, has already launched its first range of cosmetic cannabis-based products in Europe.​ The company is now working on becoming a fully integrated medical cannabis entity with interests in sales, distribution, growing and R&D.​ A recent agreement to acquire Panax Pharma, a licensed Czech-based medical cannabis company is set to fast track its ambitions.​ To ensure it has the funds to fulfil its goals, this company has just closed a $5M capital raising to sophisticated and institutional investors, at 4.4 cents a share.​ Meanwhile, retail investors, who are holders of the stock on the record date of 13 May, can participate in a company capital raise on the same terms as the sophisticated investors via a Priority Rights Offer (PRO). The date means new investors to the company are still be able to participate in the PRO.​ The company seeking to raise up to $2M via the PRO, but could see oversubscriptions of a further $0.5M.​ The information in this email should not be the only trigger for your investment decision. Click on the link below for a more in-depth and informed examination of the company. We strongly recommend you seek professional financial advice whenever making financial investment decisions.​ This company was the first ASX-listed company to sign a wholesale CBD offtake agreement for its product - to the value of $60M, and it has managed to deliver on its initial target of commercialising medical cannabis cosmetic products as early as 2016.​ With that in mind the company's commercial future looks bright.​

	Column 1
0	Column 1 0 ​

[/table]

Column 1

0

Column 1 0 Regular readers of The Next Oil Rush, The Next Mining Boom, The Next Small Cap and The Next Tech Stock will know that we have a stellar track record of identifying high potential companies.​ 88E has been up over 680%, TSX:AOI has been up over 600%, MOZ as high as 360%, ADV as high as 380%, and EMH as high as 260% since we published articles on these stocks.​ ZIP has been as high as 460%, LIT as high as 340%, BLK as high as 200%, RLE as high as 110%, and CZL as high as 100% since we published articles on these stocks.​

[/table]